These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28562357)
1. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis. Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357 [TBL] [Abstract][Full Text] [Related]
2. The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis. Wang J; Shen C; Fu Y; Yu T; Song J Onco Targets Ther; 2017; 10():1725-1734. PubMed ID: 28356760 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma. Bianconi M; Faloppi L; Loretelli C; Zizzi A; Giampieri R; Bittoni A; Andrikou K; Del Prete M; Burattini L; Montironi R; Scartozzi M; Cascinu S Oncotarget; 2016 Jun; 7(25):37599-37607. PubMed ID: 27175586 [TBL] [Abstract][Full Text] [Related]
4. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma. Liu F; Wen T; Tang Q; Chen F; Liao D Nephron; 2020; 144(5):255-260. PubMed ID: 32182617 [TBL] [Abstract][Full Text] [Related]
5. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis. Tang J; Qin Z; Li X; Han P; Wang F; Yang C; Li R; Wang K; Tang M; Wang W; Lv Q; Zhang W Oncotarget; 2017 Jul; 8(30):50034-50050. PubMed ID: 28489583 [TBL] [Abstract][Full Text] [Related]
6. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects. Song Y; Yang Y; Liu L; Liu X Gene; 2019 May; 698():186-197. PubMed ID: 30849545 [TBL] [Abstract][Full Text] [Related]
7. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals. Wang K; Liu L; Zhu ZM; Shao JH; Xin L Cytokine; 2011 Nov; 56(2):167-73. PubMed ID: 21798757 [TBL] [Abstract][Full Text] [Related]
8. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects. Song Y; Hu J; Chen Q; Guo J; Zou Y; Zhang W; Chen X; Hu W; Huang P Gene; 2018 Dec; 679():241-252. PubMed ID: 30195633 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies. Gong M; Dong W; Shi Z; Qiu S; Yuan R Oncotarget; 2017 Jan; 8(5):8447-8458. PubMed ID: 28039484 [TBL] [Abstract][Full Text] [Related]
10. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population. Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110 [TBL] [Abstract][Full Text] [Related]
11. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population. Sáenz-López P; Vazquez F; Cozar JM; Carretero R; Garrido F; Ruiz-Cabello F Hum Immunol; 2013 Jan; 74(1):98-103. PubMed ID: 23073296 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas. Xian W; Zheng H; Wu WJ Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443 [TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis. Ma WQ; Wang Y; Han XQ; Zhu Y; Liu NF BMC Med Genet; 2018 Jul; 19(1):108. PubMed ID: 29973139 [TBL] [Abstract][Full Text] [Related]
14. Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: A meta-analysis. Xie XJ; Yang YM; Jiang JK; Lu YQ J Diabetes; 2017 Aug; 9(8):738-753. PubMed ID: 27613596 [TBL] [Abstract][Full Text] [Related]
15. Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration. Liu Y; Hou S; Lang W; Dai D; Wang Z; Ji X; Li K; Zhang X; Zou Y; Wang J Genet Test Mol Biomarkers; 2014 Apr; 18(4):245-52. PubMed ID: 24689893 [TBL] [Abstract][Full Text] [Related]
16. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study. Shen BL; Qu QS; Miao SZ; Zhang YX Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342 [TBL] [Abstract][Full Text] [Related]
17. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma. Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121 [TBL] [Abstract][Full Text] [Related]
18. Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population. Fu D; Li P; Cheng W; Tian F; Xu X; Yi X; Tang C; Wang Y; Hu Q; Zhang Z Oncotarget; 2017 Apr; 8(14):22927-22935. PubMed ID: 28206971 [TBL] [Abstract][Full Text] [Related]
19. Association of the vascular endothelial growth factor gene polymorphisms (-460C/T, +405G/C and +936T/C) with endometriosis: a meta-analysis. Xu S; Wu W; Sun H; Lu J; Yuan B; Xia Y; De Moor B; Marchal K; Wang X; Xu P; Cheng W Ann Hum Genet; 2012 Nov; 76(6):464-71. PubMed ID: 23061744 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis. Huang C; Xu Y; Li X; Wang W Mol Vis; 2013; 19():1211-21. PubMed ID: 23761723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]